Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach for Hip Surgery

NCT04628923 | Unknown Phase 3

• 1 other identifier: FMBSUREC/05072020/AbdEl Badei2
• Study Type: interventional
• Target: 5
• Locations: 0 countries
• Sites: N/A

Brief Summary

The quadratus lumborum block (QLB) was first described by Blanco. it is a compartment block procedure during which a local anesthetic is injected into the muscle plane of the quadratus lumborum (QL) muscle under ultrasound guidance Currently, QLB is divided into four types based on the injection point of the local anesthetic: lateral, anterior, posterior, and intramuscular QLB. QLB is widely used for various types of abdominal surgeries (

Conditions

Self Efficacy

Outcome Measures

Primary Outcomes (1)

• sensory and motor block level

  BY PIN PRICK

  immediately after the intervention/procedure/surgery

Study Arms (1)

QLB

EXPERIMENTAL

With the patient in the lateral decubitus and the block side independent, a curvilinear ultrasound transducer (2-5 MHz) will be directed caudally in a sagittal plane 3-4 cm lateral to the lumbar spinous process of L4, which is almost opposite to the iliac crest, producing a longitudinal scan of the lumbar paravertebral region; and thus identifying the transverse processes of L3 and L4, with PM muscle in-between and erector spinae muscle posteriorly. The probe is shifted slowly to the lateral side until the transverse processes disappear and the QL muscle is evident in its long axis attached caudally to the iliac crest with a characteristic sonographic image of three muscle layers appearing from posterior to anterior as: erector spinae, QL, and PM muscles respectively.

Other: QUADRATUS LUMBORUM BLOCK

Interventions

QUADRATUS LUMBORUM BLOCK OTHER

QUADRATUS LUMBORUM BLOCK BY PARASPINOUS SAGITTAL SHIFT APPROACH

QLB

Eligibility Criteria

• Age: 30 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• ASA I and II

You may not qualify if:

• Contraindications for regional blocks (eg. Patient refusal Infection at the injection site, coagulopathy)
• Allergic reaction to drugs.
• opium addiction, any drug or substance abuse and chronic treatment with opium, non-steroidal anti-inflammatory drugs

Sponsors & Collaborators

• Beni-Suef University: lead

Study Design

• Study Type: interventional
• Phase: phase 3
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor Doaa Rashwan

Study Record Dates

• First Submitted: September 18, 2020
• First Posted: November 16, 2020
• Study Start: November 20, 2020
• Primary Completion: December 30, 2020
• Study Completion: December 30, 2020
• Last Updated: November 16, 2020

Record last verified: 2020-11

Data Sharing

• IPD Sharing: Will not share